$18.12
-0.330 (-1.79%)
At Close: Jun 03, 2026
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020
08:05pm, Thursday, 30'th Jul 2020
RANCHO CUCAMONGA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2020 ended June 30,
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: Should You Buy?
04:33pm, Wednesday, 29'th Jul 2020
Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Stock Holdings Lifted by AQR Capital Management LLC
08:00am, Saturday, 04'th Jul 2020
AQR Capital Management LLC lifted its position in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) by 130.4% during the 1st quarter, according to the company in its most recent disclosure with the Securiti
Are Robust Financials Driving The Recent Rally In Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock?
03:59pm, Friday, 03'rd Jul 2020
Amphastar Pharmaceuticals (NASDAQ:AMPH) has had a great run on the share market with its stock up by a significant 48...
Needham Downgrades Zynerba Pharmaceuticals (ZYNE) to Hold - Markets
11:24am, Wednesday, 01'st Jul 2020
In a report released today, Serge Belanger from Needham downgraded Zynerba Pharmaceuticals (ZYNE – Research Report) to Hold. The company’s
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
10:13am, Wednesday, 01'st Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on G1 Therapeutics
Northland Securities Maintains a Buy Rating on Verrica Pharmaceuticals (VRCA) - Markets
11:49am, Tuesday, 30'th Jun 2020
Northland Securities analyst Tim Chiang maintained a Buy rating on Verrica Pharmaceuticals (VRCA – Research Report) today and set a
Analysts Are Bullish on These Healthcare Stocks: Verrica Pharmaceuticals (VRCA), Intercept Pharma (ICPT) - Markets
10:08am, Tuesday, 30'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Verrica Pharmaceuticals
Needham Assigns a Buy Rating on Zogenix (ZGNX) - Markets
10:00am, Monday, 29'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Zogenix (ZGNX – Research Report), with
Collegium Pharmaceutical (COLL) Gets a Buy Rating from Needham - Markets
12:34pm, Friday, 26'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report),
Aerie Pharma (AERI) Gets a Buy Rating from Needham - Markets
12:16pm, Friday, 26'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Aerie Pharma (AERI – Research Report),
Collegium Pharmaceutical (COLL) Gets a Buy Rating from Needham - Markets
01:00pm, Friday, 19'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report),
Needham Maintains a Buy Rating on Aerie Pharma (AERI) - Markets
12:55pm, Friday, 19'th Jun 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Aerie Pharma (AERI – Research Report),
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
10:05am, Friday, 19'th Jun 2020
Amphastar Pharmaceuticals, Inc. (AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate Communications and Human Resources, and Tony Marrs, Sr. Vice President Regulator
$84.30 Million in Sales Expected for Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) This Quarter
07:14am, Monday, 15'th Jun 2020
Equities research analysts expect that Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) will post sales of $84.30 million for the current quarter, Zacks reports. Four analysts have issued estimates for Amp
Sign In
Buy AMPH